Company research
Vaxxinity, Inc.
CIK 1851657Updated Sep 24, 2026
SecurityVAXX · OTC · equity
VAXX price & chart
Loading TradingView…
OTC:VAXX on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 44,311,000Source | 106,399,000Source | 166,673,000Source | 50,141,000Source |
| Property, Plant and Equipment, NetUSD | 11,081,000Source | 12,512,000Source | 12,173,000Source | 12,158,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,931,000Source | 33,475,000Source | 144,885,000Source | 31,143,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | 0Source | 26,000Source |
| Assets, CurrentUSD | 33,230,000Source | 93,887,000Source | 154,129,000Source | 35,674,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,316,000Source | 5,551,000Source | 8,851,000Source | 4,144,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 30,902,000Source | 44,222,000Source | 38,054,000Source | 75,041,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 374,760,000Source | 366,799,000Source | 357,822,000Source | 4,682,000Source |
| Retained Earnings (Accumulated Deficit)USD | -361,637,000Source | -304,703,000Source | -229,481,000Source | -92,306,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 8,000Source | -197,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 13,409,000Source | 62,177,000Source | 128,619,000Source | -87,375,000Source |
| Liabilities and EquityUSD | 44,311,000Source | 106,399,000Source | 166,673,000Source | 50,141,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 17,605,000Source | 30,941,000Source | 27,494,000Source | 39,358,000Source |
| Accounts Payable, CurrentUSD | — | 5,295,000Source | 3,192,000Source | 1,017,000Source |
| Other Liabilities, NoncurrentUSD | 35,000Source | 236,000Source | 237,000Source | 249,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | — | — | 61,000Source | 130,000Source |
| Short-term InvestmentsUSD | 25,464,000Source | 53,352,000Source | — | — |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 7,508,000Source | 8,714,000Source | 280,000Source | 0Source |
| Deferred Income Tax Expense (Benefit)USD | — | 0Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -57,238,000Source | -55,928,000Source | -80,990,000Source | -33,910,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 28,844,000Source | -54,392,000Source | -1,318,000Source | -1,477,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 803,000Source | 1,866,000Source | 1,318,000Source | 1,477,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,140,000Source | -167,000Source | 66,109,000Source | 196,167,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -29,534,000Source | -110,487,000Source | 30,722,000Source | 113,859,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 5,036,000Source | 34,570,000Source | 145,057,000Source | 31,198,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 799,000Source | 367,000Source | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 7,508,000Source | 8,714,000Source | 1,014,000Source | 30,412,000Source |
| Amortization of Debt Issuance CostsUSD | 51,000Source | 53,000Source | 261,000Source | 108,000Source |
| Amortization of Intangible AssetsUSD | — | — | 100,000Source | — |
| DepreciationUSD | 2,234,000Source | 1,684,000Source | 1,102,000Source | 717,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -43,000Source | 12,000Source | 23,000Source | 77,000Source |
| General and Administrative ExpenseUSD | 22,386,000Source | 28,352,000Source | 51,825,000Source | 12,217,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | 0Source | 0Source |
| Investment Income, InterestUSD | 2,090,000Source | 1,259,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -56,934,000Source | -75,222,000Source | -137,175,000Source | -39,957,000Source |
| Operating ExpensesUSD | 58,285,000Source | 75,979,000Source | 123,204,000Source | 32,787,000Source |
| Other Nonoperating Income (Expense)USD | 1,351,000Source | 757,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 454,000Source | 263,000Source | 79,000Source | 170,000Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | — | 0Source | 66,000Source | 557,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -58,285,000Source | -75,979,000Source | -125,075,000Source | -32,282,000Source |
| Other Nonoperating Income (Expense)USD | 1,351,000Source | 757,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -56,934,000Source | -75,222,000Source | -137,175,000Source | -39,957,000Source |
| Income Tax Expense (Benefit)USD | — | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -56,934,000Source | -75,222,000Source | -137,175,000Source | -39,957,000Source |
| Earnings Per Share, BasicUSD per share | -0.45Source | -0.6Source | — | — |
| Earnings Per Share, DilutedUSD per share | -0.45Source | -0.6Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 126,508,917Source | 125,939,050Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 126,508,917Source | 125,939,050Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | — | 100,000Source | — |
| Current Income Tax Expense (Benefit)USD | — | 0Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -43,000Source | 12,000Source | 23,000Source | 77,000Source |
| General and Administrative ExpenseUSD | 22,386,000Source | 28,352,000Source | 51,825,000Source | 12,217,000Source |
| Gross ProfitUSD | — | 0Source | -1,871,000Source | 505,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -54,850,000Source | -69,943,000Source | -128,538,000Source | -31,053,000Source |
| Interest ExpenseUSD | 696,000Source | 514,000Source | 840,000Source | 1,182,000Source |
| Investment Income, InterestUSD | 2,090,000Source | 1,259,000Source | — | — |
| Operating ExpensesUSD | 58,285,000Source | 75,979,000Source | 123,204,000Source | 32,787,000Source |
| Research and Development ExpenseUSD | 35,899,000Source | 47,627,000Source | 71,379,000Source | 20,570,000Source |